Hisoler, Chizelle C.
HRN: 22-19-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2022
CEFUROXIME 1.5GM (VIAL)
11/14/2022
11/14/2022
ORAL
1.5g
Now
Endometrial Hyperplasia
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes